Updated Jul 16, 2026
Fowler John Franklin has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Fowler John Franklin is the name listed in SEC filings as affiliated with Kezar Life Sciences, Inc. as of the 2026-05-11 filing. The publicly available filings do not clearly disclose his exact role (e.g., director, officer) or provide a detailed professional background. Additional verification from Kezar Life Sciences’ investor materials or the SEC EDGAR filing itself would be needed to confirm current title, background, and responsibilities. This entry notes potential name variations (e.g., John Franklin Fowler, John F. Fowler) that may appear in related documents.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-11 | KZR | Kezar Life Sciences, Inc. | J — Other acquisition / disposition | 3.8K | — | |
| 2026-05-11 | KZR | Kezar Life Sciences, Inc. | J — Other acquisition / disposition | 375 | — | |
| 2026-05-11 | KZR | Kezar Life Sciences, Inc. | J — Other acquisition / disposition | 39.4K | — |
Fowler John Franklin is the name listed in SEC filings as affiliated with Kezar Life Sciences, Inc. as of the 2026-05-11 filing. The publicly available filings do not clearly disclose his exact role (e.g., director, officer) or provide a detailed professional background. Additional verification from Kezar Life Sciences’ investor materials or the SEC EDGAR filing itself would be…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Fowler John Franklin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.